Jilin Aodong Pharmaceutical Group Co Ltd (000623) — Free Cash Flow Generation Index
Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Free Cash Flow Generation Index of 0.77x as of September 2025. Free cash flow of CN¥86.32 Million represents 1% of operating cash flow (CN¥112.12 Million). Explore how much does Jilin Aodong Pharmaceutical Group Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jilin Aodong Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (1999–2025)
Historical FCF Generation Index trend for Jilin Aodong Pharmaceutical Group Co Ltd across 26 annual periods. For the full cash flow conversion analysis, see 000623 cash flow conversion.
Annual Free Cash Flow Generation for Jilin Aodong Pharmaceutical Group Co Ltd (1999–2025)
Year-by-year Free Cash Flow Generation Index for Jilin Aodong Pharmaceutical Group Co Ltd. Check 000623 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.53x | CN¥143.81 Million | CN¥272.26 Million | CN¥128.45 Million | ▲ +114.6% |
| 2024 | -3.61x | CN¥-214.50 Million | CN¥59.48 Million | CN¥273.98 Million | ▲ +30.2% |
| 2023 | -5.16x | CN¥-351.46 Million | CN¥68.06 Million | CN¥419.52 Million | ▼ -1531.6% |
| 2022 | 0.36x | CN¥152.89 Million | CN¥423.86 Million | CN¥270.97 Million | ▲ +915.0% |
| 2021 | 0.04x | CN¥11.54 Million | CN¥324.85 Million | CN¥313.30 Million | ▼ -91.5% |
| 2020 | 0.42x | CN¥163.02 Million | CN¥390.41 Million | CN¥227.38 Million | ▲ +0.9% |
| 2019 | 0.41x | CN¥157.06 Million | CN¥379.46 Million | CN¥222.40 Million | ▲ +40.6% |
| 2018 | 0.29x | CN¥102.33 Million | CN¥347.64 Million | CN¥245.30 Million | ▼ -56.2% |
| 2017 | 0.67x | CN¥172.56 Million | CN¥256.49 Million | CN¥83.93 Million | ▲ +27.8% |
| 2016 | 0.53x | CN¥175.79 Million | CN¥333.81 Million | CN¥158.03 Million | ▲ +279.0% |
| 2015 | 0.14x | CN¥53.92 Million | CN¥388.03 Million | CN¥334.11 Million | ▲ +135.5% |
| 2014 | -0.39x | CN¥-113.18 Million | CN¥288.83 Million | CN¥402.01 Million | ▲ +26.8% |
| 2013 | -0.54x | CN¥-107.79 Million | CN¥201.22 Million | CN¥309.01 Million | ▼ -168.3% |
| 2012 | -0.20x | CN¥-54.40 Million | CN¥272.40 Million | CN¥326.80 Million | ▲ +93.8% |
| 2011 | -3.23x | CN¥-349.42 Million | CN¥108.30 Million | CN¥457.72 Million | ▼ -2628.9% |
| 2010 | 0.13x | CN¥22.23 Million | CN¥174.22 Million | CN¥152.00 Million | ▼ -84.6% |
| 2009 | 0.83x | CN¥176.51 Million | CN¥213.03 Million | CN¥36.51 Million | ▼ -4.3% |
| 2008 | 0.87x | CN¥203.51 Million | CN¥235.03 Million | CN¥31.52 Million | ▼ -3.6% |
| 2007 | 0.90x | CN¥345.45 Million | CN¥384.69 Million | CN¥39.24 Million | ▲ +28.7% |
| 2006 | 0.70x | CN¥131.12 Million | CN¥187.99 Million | CN¥56.87 Million | ▲ +18.0% |
| 2005 | 0.59x | CN¥80.57 Million | CN¥136.26 Million | CN¥55.68 Million | ▼ -25.0% |
| 2004 | 0.79x | CN¥172.35 Million | CN¥218.53 Million | CN¥46.19 Million | ▲ +108.8% |
| 2003 | 0.38x | CN¥55.76 Million | CN¥147.65 Million | CN¥91.89 Million | ▲ +176.4% |
| 2001 | -0.49x | CN¥-68.61 Million | CN¥138.76 Million | CN¥207.37 Million | ▲ +56.1% |
| 2000 | -1.13x | CN¥-86.86 Million | CN¥77.04 Million | CN¥163.90 Million | ▼ -413.2% |
| 1999 | 0.36x | CN¥39.66 Million | CN¥110.18 Million | CN¥70.52 Million | — |